U.S. Communications Stock News

NYSE:BALL
NYSE:BALLPackaging

Ball (BALL) Is Up 9.7% After Guiding Double-Digit 2026 EPS Growth And Maintaining Dividend

In early February 2026, Ball Corporation reported fourth-quarter 2025 results showing sales of US$3,347 million and net income of US$200 million, alongside full-year 2025 sales of US$13.16 billion and diluted earnings per share from continuing operations of US$3.30. Management also projected comparable diluted earnings per share growth of above 10% for 2026 and affirmed a quarterly dividend of US$0.20 per share, underscoring confidence in Ball’s post-divestiture, aluminum-packaging-focused...
NYSE:MNTN
NYSE:MNTNMedia

High Growth Tech Stocks In The US February 2026

As February 2026 begins, the U.S. stock market has seen a robust start with major indices like the Dow Jones Industrial Average and S&P 500 showing significant gains, reflecting positive investor sentiment despite recent economic uncertainties such as government shutdowns and changes in Federal Reserve leadership. In this dynamic environment, identifying high-growth tech stocks requires careful consideration of factors such as innovation potential, adaptability to market shifts, and financial...
NYSE:XPEV
NYSE:XPEVAuto

Discover Autodesk And 2 Other Stocks Estimated To Be Trading Below Fair Value

As the U.S. stock market kicks off February with significant gains, highlighted by the Dow Jones Industrial Average's 515-point surge and the S&P 500 nearing a record high, investors are keenly observing opportunities amid this bullish sentiment. In such an environment, identifying stocks that may be trading below their fair value can present potential investment opportunities, particularly when considering companies like Autodesk and others that might offer strong fundamentals at attractive...
NYSE:PAY
NYSE:PAYDiversified Financial

High Insider Ownership Fuels Growth Stocks In February 2026

As February 2026 begins, U.S. stock markets have shown strong momentum with major indexes like the Dow and S&P 500 ending sharply higher, reflecting investor optimism amid recent economic developments such as trade deals and manufacturing growth. In this buoyant market environment, companies with high insider ownership often attract attention as their leadership's vested interest can signal confidence in long-term growth potential.
NasdaqGS:UDMY
NasdaqGS:UDMYConsumer Services

Cassava Sciences And 2 Other Promising Penny Stocks

As February begins, major U.S. stock indexes have shown a strong start, with the Dow Jones Industrial Average adding 515 points and the S&P 500 nearing record highs. In this context of market optimism, investors may find interest in exploring penny stocks—an investment area that often involves smaller or newer companies. Although the term "penny stocks" might seem outdated, these investments can still offer surprising value and potential for growth when backed by solid financial health.
NasdaqCM:ISBA
NasdaqCM:ISBABanks

Undiscovered Gems in the US Market This February 2026

As February 2026 begins, the U.S. stock market is experiencing a strong start with major indices like the Dow Jones and S&P 500 showing significant gains, reflecting a positive investor sentiment despite recent economic uncertainties such as delayed jobs data due to a government shutdown. In this vibrant yet complex environment, identifying promising small-cap stocks requires careful consideration of factors like market resilience and growth potential amidst evolving economic conditions.
NasdaqGM:CBFV
NasdaqGM:CBFVBanks

Top Dividend Stocks To Consider In February 2026

As February 2026 begins, the U.S. stock market has shown a robust start with major indexes like the Dow Jones Industrial Average and S&P 500 posting significant gains. In this dynamic market environment, dividend stocks can offer investors a blend of income and potential growth, making them an attractive consideration amidst ongoing economic developments.
NasdaqGS:HUMA
NasdaqGS:HUMABiotechs

Why Humacyte (HUMA) Is Up 5.1% After New DoD Funding Backs Symvess Trauma Use

In February 2026, Humacyte, Inc. reported that the U.S. Department of Defense’s Fiscal Year 2026 Appropriations Act includes dedicated funding to evaluate and incorporate biologic vascular repair technologies, directly aligning with its FDA-approved human-derived bioengineered blood vessel Symvess for traumatic extremity vascular injuries in service members. This federal support highlights growing institutional recognition of bioengineered human vessels as an off-the-shelf option when...
NYSE:EVMN
NYSE:EVMNBiotechs

Evommune (EVMN) Valuation Check After Positive Phase 2a EVO301 Results In Atopic Dermatitis

Evommune (EVMN) is back in focus after reporting statistically significant positive top-line results from its Phase 2a EVO301 trial in moderate to severe atopic dermatitis, including clear separation from placebo and a favorable safety readout. See our latest analysis for Evommune. The positive EVO301 data has coincided with a sharp re-rating in the stock, with a 1-day share price return of 70.87% and a year-to-date share price return of 67.71% off a last close of $29.03. This indicates...
NYSE:SBSI
NYSE:SBSIBanks

A Look At Southside Bancshares (SBSI) Valuation After Its 2025 Earnings And Capital Returns Update

Southside Bancshares (SBSI) shares are trading around $33.30 after the bank reported full year 2025 results, which showed higher net interest income but lower net income and earnings per share compared with 2024. See our latest analysis for Southside Bancshares. The stock’s recent performance reflects mixed sentiment, with a 15.54% 90 day share price return and 9.36% year to date share price return. The 3 year total shareholder return is slightly negative and the 5 year total shareholder...
NYSE:CNA
NYSE:CNAInsurance

CNA Financial (CNA) Earnings Story Centers On Stronger P&C Combined Ratios Challenging Cautionary Narratives

CNA Financial (CNA) has wrapped up FY 2025 with fourth quarter total revenue of US$3.8 billion, basic EPS of US$1.11 and net income of US$302 million. Its trailing twelve month figures show revenue of US$15.0 billion, EPS of US$4.71 and net income of US$1.28 billion. Over the past year, the company has seen revenue move from US$14.3 billion to US$15.0 billion and trailing EPS shift from US$3.53 to US$4.71. This sets the backdrop for how you might read this latest print. With net profit margin...
NasdaqGS:FROG
NasdaqGS:FROGSoftware

Is It Too Late To Consider JFrog (FROG) After 48% One-Year Surge?

If you are wondering whether JFrog shares at about US$53.20 still offer value, you are not alone. This article breaks down what that price might really represent. The stock has been volatile, with a 2.7% return over the last 7 days, a 10.2% decline over 30 days, a 10.7% decline year to date, and a 48.0% return over 1 year, alongside a 119.8% return over 3 years and a 23.2% decline over 5 years. Recent coverage of JFrog has focused on its role in software development tooling and how investors...
NasdaqGM:ALVO
NasdaqGM:ALVOBiotechs

Assessing Alvotech (ALVO) Valuation After AVT80 Trial Success And New Sandoz Agreements

Alvotech (ALVO) shares have been in focus after the company reported positive top line pharmacokinetic data for its AVT80 biosimilar candidate to Entyvio, along with new supply and commercialization agreements with Sandoz in Canada, Australia and New Zealand. See our latest analysis for Alvotech. These fresh clinical results and the Sandoz agreements come after a mixed share price pattern, with a 12.07% 1 month share price return and a 4.00% year to date share price return contrasting with a...
NYSE:RHP
NYSE:RHPHotel and Resort REITs

Ryman Hospitality Properties (RHP) Is Up 7.3% After Expanding Its Revolving Credit Facility - What's Changed

In January 2026, Ryman Hospitality Properties, Inc. refinanced and expanded its revolving credit facility from US$700,000,000 to US$850,000,000, extending the initial maturity to January 2030 while keeping pricing and most terms largely unchanged and updating several key financial covenants. This refinancing gives Ryman greater committed liquidity and a longer funding runway, potentially enhancing its flexibility to manage leverage, secured debt levels, and future capital needs under clearly...
NYSE:DAC
NYSE:DACShipping

Danaos (DAC) Margins Stay Near 47% Trailing Level Testing Bullish Profitability Narratives

Setting the scene with Danaos's latest numbers Danaos (DAC) has just wrapped up FY 2025 with fourth quarter revenue of US$266.3 million and basic EPS of US$6.43, capping a year in which trailing twelve month revenue sat at about US$1.0 billion and EPS at US$26.83. The company has seen revenue move from US$258.2 million and EPS of US$4.72 in Q4 2024 to the latest Q4 2025 figures. Over the same period, trailing twelve month revenue slipped from US$1.01 billion and EPS from US$26.15 a year...
NYSE:CNMD
NYSE:CNMDMedical Equipment

Does CONMED (CNMD) Prioritize Revenue Growth Over Profitability After 2025 Earnings Compression?

In late January 2026, CONMED Corporation reported fourth-quarter 2025 sales of US$373.2 million and full-year sales of US$1.37 billion, alongside a sharp year-on-year fall in net income to US$16.74 million for the quarter and US$47.06 million for the year. While revenue increased, the sizeable drop in earnings per share from continuing operations to US$0.54 for the quarter and US$1.51 for the year, combined with 2026 revenue guidance of US$1.345–1.375 billion, highlights a tension between...
NasdaqGS:HWKN
NasdaqGS:HWKNChemicals

Hawkins Wins Orange County Reuse Deal As NanoStack Thesis Builds

Hawkins' subsidiary WaterSurplus will supply 1,050 NanoStack coated membranes to the Orange County Water District’s Groundwater Replenishment System. The decision follows a successful pilot and represents deployment into what is described as the world’s leading potable water reuse system. The project highlights Hawkins' role in advanced water treatment solutions for large scale reuse facilities. For investors watching NasdaqGS:HWKN, this contract sits alongside a share price of $143.51 and...
NYSE:NTB
NYSE:NTBBanks

Butterfield Bank (NTB) Net Interest Margin Holds At 2.69% Challenging Bearish Profitability Narratives

How Bank of N.T. Butterfield & Son (NYSE:NTB)'s FY 2025 Numbers Set the Stage Bank of N.T. Butterfield & Son (NYSE:NTB) has reported a clean set of FY 2025 numbers, with fourth quarter revenue of US$159.1 million and basic EPS of US$1.58 anchoring the latest release. Over the past year, the bank has recorded trailing twelve month revenue of US$606.7 million and basic EPS of US$5.71. This gives investors a fuller picture of how the quarterly performance fits within the broader trend. With a...
NasdaqGS:CGNX
NasdaqGS:CGNXElectronic

Assessing Cognex (CGNX) Valuation After Recent Share Price Momentum And Mixed Long Term Returns

What recent returns suggest about Cognex (CGNX) Cognex (CGNX) has delivered a 0.1% move over the past day, with gains of 6.7% over the past week and around 12% over the past month, leaving the shares near US$43.58. Over the past 3 months the stock shows a total return of about 14%, while the 1 year total return is roughly 11%. Longer term, 3 year and 5 year total returns sit in negative territory. See our latest analysis for Cognex. For Cognex, the recent 7 day and 30 day share price returns...
NYSE:SITE
NYSE:SITETrade Distributors

Does SiteOne’s Margin Improvement Reveal a New Phase in SITE’s Profitability Playbook?

SiteOne Landscape Supply reported its fourth-quarter 2025 results, with sales rising to US$1,045.6 million and its quarterly net loss narrowing to US$9 million, while full-year sales reached US$4,704.8 million and net income increased to US$151.8 million. The company also improved its earnings per share from continuing operations for the full year, with diluted EPS rising from US$2.71 to US$3.37, underlining higher profitability on slightly higher revenue. We’ll now examine how this...
NasdaqGS:ICHR
NasdaqGS:ICHRSemiconductor

Ichor Holdings (ICHR) EPS Loss Of US$0.46 Tests Bullish Turnaround Narratives

Ichor Holdings (ICHR) just wrapped up FY 2025 with Q4 revenue of US$223.6 million and a basic EPS loss of US$0.46, while trailing twelve month figures show revenue of US$947.7 million and a basic EPS loss of US$1.54. Over recent quarters, the company has seen quarterly revenue move between US$211.1 million and US$244.5 million, with basic EPS losses ranging from US$0.08 to US$0.67. This pattern keeps the focus squarely on how efficiently each dollar of sales is translating into earnings. With...